NorthStrive Fund II

NorthStrive Fund II LP is an activist investment vehicle and a subsidiary of NorthStrive Companies Inc., a Newport Beach-based management and investment firm. The fund specializes in strategic investments within the life sciences and healthcare sectors, frequently employing activist strategies to drive shareholder value and corporate restructuring. In early 2026, NorthStrive Fund II gained prominence for its activist position in enVVeno Medical (NASDAQ: NVNO), where it advocated for a cessation of clinical spending and the pursuit of strategic alternatives such as liquidation or an accretive merger. The fund is part of the NorthStrive ecosystem founded by Braeden Lichti, which also includes NorthStrive Biosciences, a biopharmaceutical company developing treatments for obesity and muscle preservation.